U of M, Mayo Clinic cultivate close ties to drug companies - Bring Me The News

U of M, Mayo Clinic cultivate close ties to drug companies

In part three in a series investigating drug company's financial relationships with health care practitioners, the Pioneer Press looks into the University of Minnesota and Mayo Clinic, two big organizations that are getting a growing share of industry money. Both organizations use the money for research and training, and both have processes in place to root out possible conflicts of interest.
Author:
Publish date:

In part three in a series investigating drug company's financial relationships with health care practitioners, the Pioneer Press looks into the University of Minnesota and Mayo Clinic, two big organizations that are getting a growing share of industry money. Both organizations use the money for research and training, and both have processes in place to root out possible conflicts of interest.

Next Up

Related

Mayo Clinic wins major patent victory

The Supreme Court sided unanimously with Mayo in a patent dispute with California-based Prometheus Laboratories. The clinic had used a blood test developed by Prometheus until 2004, when it developed its own in-house test. Prometheus sued for patent infringement, but Mayo argued that using test to measure a natural bodily process is not patent eligible.

U of M professor: Drugs aren't solution to kids' attention problems

A psychology professor from the University of Minnesota is making waves with an article in the Sunday New York Times. L. Alan Sroufe says medicating children is a misguided approach to treating attention disorders. "Putting children on drugs does nothing to change the conditions that derail their development in the first place," he writes.